Shares of WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up prior to trading on Tuesday. The stock had previously closed at $12.51, but opened at $12.9399. WuXi Biologics (Cayman) shares last traded at $12.52, with a volume of 46,436 shares.
Wall Street Analyst Weigh In
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.
Get Our Latest Research Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Down 3.7%
The company has a 50 day simple moving average of $12.76 and a two-hundred day simple moving average of $10.29.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
- Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-Off
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
